If women are prediabetic when giving birth, they may find it difficult to make enough breast milk to feed their newborns, according to new research from Cincinnati Children's Hospital Medical Center and the University of California, Davis. The findings show that insulin dysregulation can negatively impact milk supply.
If women are prediabetic when giving birth, they may find it difficult to make enough breast milk to feed their newborns, according to new research from Cincinnati Children's Hospital Medical Center and the University of California, Davis. The findings show that insulin dysregulation can negatively impact milk supply.
Building on a previous study, scientists suggest that insulin affects lactation success. The study authors point out theirs is the first study to explain how in the process of lactation the human mammary gland becomes extremely sensitive to insulin.
The latest study identified genes expressed in human milk-making cells that tend to be highly sensitive. During the period between the production of colostrum in the first days after giving birth and the secretion of greater volume of milk in mature lactation, several genes “switch on and off,” scientists noted.
The *PTPRF (Protein tyrosine phosphatase, receptor type, F) gene may be a biomarker for inadequate milk production. The gene stifles signals related to cells that are often triggered by insulin binding to its receptor on the cell surface.
The authors’ findings may help investigators in the future, when studying physical reasons for women having problems breastfeeding.
Upon this latest discovery, study authors plan to pursue a phase I/II clinical trial assessing a medication that is given to control blood sugar in patients with type 2 diabetes. The primary outcome will be to analyze whether this boosts insulin activity in the mammary gland, enabling prediabetic women to generate adequate breast milk.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More